Safinamide in Idiopathic Parkinson's Disease (IPD) With Motor Fluctuations, as add-on to Levodopa

NCT00627640 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

549

Enrollment

INDUSTRY

Sponsor class

Conditions

Idiopathic Parkinson's Disease

Interventions

DRUG: Safinimide 50-100 mg/day
DRUG: Matching Placebo

Sponsor

Newron Pharmaceuticals SPA